Liver Transplant Imaging prior to and during the COVID-19 Pandemic

Biomed Res Int. 2022 Jan 12:2022:7768383. doi: 10.1155/2022/7768383. eCollection 2022.

Abstract

Background: The suspension of the surgical activity, the burden of the infection in immunosuppressed patients, and the comorbidities underlying end-stage organ disease have impacted transplant programs significantly, even life-saving procedures, such as liver transplantation.

Methods: A review of the literature was conducted to explore the challenges faced by transplant programs and the adopted strategies to overcome them, with a focus on indications for imaging in liver transplant candidates.

Results: Liver transplantation relies on an appropriate imaging method for its success. During the Coronavirus Disease 2019 (COVID-19) pandemic, chest CT showed an additional value to detect early signs of SARS-CoV-2 infection and other screening modalities are less accurate than radiology.

Conclusion: There is an emerging recognition of the chest CT value to recommend its use and help COVID-19 detection in patients. This examination appears highly sensitive for liver transplant candidates and recipients, who otherwise would have not undergone it, particularly when asymptomatic.

Publication types

  • Review

MeSH terms

  • COVID-19 / diagnostic imaging
  • COVID-19 / epidemiology*
  • COVID-19 Testing*
  • Contrast Media
  • Humans
  • Immunocompromised Host
  • Liver / diagnostic imaging*
  • Liver Transplantation* / methods
  • Magnetic Resonance Imaging
  • Pandemics
  • Practice Guidelines as Topic
  • Tissue Donors
  • Tomography, X-Ray Computed
  • Ultrasonography, Doppler, Color / methods

Substances

  • Contrast Media